Naveen Pemmaraju: The New WHO Classification of Tumors book 5th Edition is now out
Naveen Pemmaraju posted on LinkedIn:
“It’s now here! The New WHO Classification of Tumors book 5th Edition is now out hot off the press!! I am proud have contributed to the new BPDCN chapter alongside my co-authors!”
Source: Naveen Pemmaraju/LinkedIn
Naveen Pemmaraju is a Professor and Director of BPDCN Program at the Department of Leukemia at the University of Texas MD Anderson Cancer Center (MDACC) and Executive Director of MDACC Network. He is also the Leukemia Hematology/Oncology Course Director.
His research work has been focused on improving outcomes and developing novel therapies for patients with rare, and ultra-rare, myeloid malignancies; including adolescents, young adults, and older adult patients with Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN), MPN and AML.